MedBud is active on Twitter, follow us today for development updates, prescription changes and general info: @MedBudCIC

Back to Noidecs or All Flower/Bud

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Strain Estimate)

MyrceneMajorHerbal/Musk166-168℃
LimoneneMajorCitrus/Sour177℃
CaryophylleneMajorPepper/Spice119℃

MedBud currently tracks 16 common terpenes, more will be added.

Medication Details

Brand
United Kingdom Noidecs
Designation
T17
Cultivar/Strain
Shishkaberry
Classification
Indica
Chemotype
Type I: High THC
Flower Provided
Trimmed Buds
THC Potential Range (±10%)
15.3-18.7%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
Germany PS Pharma
Cultivated or Packaged in
Flag of Germany Germany
Irradiation
Non-Irradiated
Imported by
United Kingdom Eaststone
Imported as
Schedule II: Finished Product

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Awaiting ETA

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Product DescriptionPatient Reviews

About Shishkaberry

SkBIndica

This strain comes from unknown growers yet won second place for best indica at the 2001 High Times’ Cannabis Cup. A bit of a mysterious gal, Shishkaberry is a cross between DJ Short Blueberry and an unknown Afghani strain.

🇳🇱 Dutch Bred, 🇦🇫 Afghani Genetics

Plan your day accordingly, because Shishkaberry can sneak up on you if you aren’t careful. An indica-dominant hybrid measuring at 80/20, this strain comes from unknown growers yet won second place for best indica at the 2001 High Times’ Cannabis Cup. A bit of a mysterious gal, Shishkaberry is a cross between DJ Short Blueberry and an unknown Afghani strain. Users love the smell and taste, as well as enjoying an intense high with a variety of effects.

Shishkaberry may not be best for novice users, as its THC content can max out at 26%. However, its average is a more tolerable 18%, which might allow sensitive individuals to partake in smaller amounts. Well-known for an enticing aroma and taste, your nose will be hit with a sweet and fruity berry scent. Translating seamlessly into its flavor, Shishkaberry is tasty with a slightly earthy note that balances out its sweetness. Nugs are long and dense with a shade of purple and an immense amount of frosty trichomes.

Get ready for a roller-coaster of a high with this strain, as you’ll start off with a head high that leaves you social, focused, and incredibly happy. If you have things to get done, take advantage of this time now before things change. You’ll notice that your high starts to creep over your entire body, and all thought of being productive vanishes. Shishkaberry transforms into a strong sedative, urging you to be one with your couch and lulling you into a relaxed and dreamy state. Many users find they end up falling asleep, making it a great choice a few hours before bed.

Because it’s such a potent strain, Shishkaberry is favored in the medical community for immediately relieving stress and helping those with insomnia. Its relaxing effects are great for those who experience general body pain but can also be a powerful antidote for people with more chronic conditions like Parkinson’s. Individuals who have a hard time being productive due to their medical concerns find they can get things done thanks to this strain.

Description provided by Wikileaf.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United Kingdom About Lyphe Group Ltd

Noidecs Logo

From Lyphe Group, a range of medical flowers and oils focused on giving doctors reassurance in the efficiency and consistency of our supply chain, while providing quality pharmaceutical-grade medication.

At Lyphe our vertical operations span product manufacturing, clinical care, pharmacy dispensing and doctor education. Our direct-to-patient and technology-led approach has quickly established us as the market’s largest player, with a 30% share of all patients. We have also recently entered the Australian market, where we intend to replicate our model of success.

lyphegroup.com

  New government petition approved: Introduce 'Grow Your Own' Laws for Legal Medical Cannabis Patients (CBPM) — please sign and share. 6 months to achieve 10,000 signatures.

  Information provided is partially community-sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)